Diabetes. Diabetes mellitus
Conditions
Interventions
Intervention 1: The placebo will be prescribed one tablet orally per day to the control group for two months. Intervention 2: The herbal formulation will be prescribed one tablet orally per day to the
Treatment - Drugs
The placebo will be prescribed one tablet orally per day to the control group for two months.
The herbal formulation will be prescribed one tablet orally per day to the intervention group for two months.
Sponsors
Iran's National Elites Foundation (INEF)
Eligibility
Sex/Gender
All
Age
30 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria:newly diagnosed diabetes according to ADA 2014 (FPG=>126 mg/dl or HgA1C=>6.4% or BS=>200 mg/dl after OGTT or random BS =>200 and hyperglycemic symptoms); age 30-65 years; signed consent form. Exclusion criteria: Diabetes type 1; insulin injection during 8 weeks ago; serious infectious diseases; renal failure (GFR< 50 cc/min/); liver failure ( high ALTor/and AST more than 3 times above normal range); cardiac failure; pregnancy and/or breast feeding; past history of seizure or epilepsy.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood Glucose. Timepoint: In the beginning and at the end of 4th and 8th weeks of the trial. Method of measurement: Blood test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood insulin. Timepoint: In the beginning and at the end of 4th and 8th weeks of the trial. Method of measurement: Blood test.;Cholesterol and triglyceride. Timepoint: In the beginning and at the end of 8th week of the trial. Method of measurement: Blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactParisa Sarkhail
Pharmaceutical Sciences Research Center
Outcome results
None listed